QRX 0.00% 2.8¢ qrxpharma ltd

oxypatch?

  1. 3,253 Posts.
    lightbulb Created with Sketch. 26
    As I expected a possible rival in the pain market to Moxduo is having problems getting of the ground.

    If they do get it off the drawing board they are hoping to register the product 2015.

    I see this product as unlikely to be of any competion.

    Some buying returning for QRX.

    Regards,
 
watchlist Created with Sketch. Add QRX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.